Diabetes, Obesity & Metabolism
Nephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney Disease
Experiments in miceSurvodutide
Papers by Thomas Klein
5 results
- ADA Scientific Sessions 2026 Abstract
Survodutide Induces Superior Weight Loss and Energy Expenditure Compared with Semaglutide in DIO Mice Housed at Thermoneutrality
Experiments in animalsInterventions - ADA Scientific Sessions 2026 Abstract
Survodutide Improves Stroke Outcome in Obese/Type 2 Diabetic Mice
Experiments in animalsInterventions - ADA Scientific Sessions 2026 Abstract
Survodutide: Differentiated GLP-1R and Glucagon Receptor (GCGR) Pharmacology Compared with Endogenous Ligands via Time-Resolved Assays
Experiments in cellsInterventions
- ADA Scientific Sessions 2025 Abstract
Survodutide Improves Heart Failure with Preserved Ejection Fraction and Dyslipidemia in a Diet-Induced Obese Hamster Model
Experiments in animalsInterventions